Molecular Designs Launches Urogenital Microbiota Panel to Detect Pathogens and Antibiotic Resistance
Urogenital Microbiota with ABX 53 Simplicity Panel™ delivers same-day research use only results, identifying 28 organisms and 25 resistance markers in a streamlined,... Read more.
Allucent Expands Leadership Team to Advance Innovation in Drug Development for Biopharma Customers
New COO, CCO, and CIO Bring Proven Operational, Commercial, and Digital Expertise to Enhance Allucent’s Biopharma Partnerships Across Its Expanding Global... Read more.
Exro Provides Corporate Update, Postpones Annual General Meeting
CALGARY, AB, Sept. 3, 2025 /PRNewswire/ – Exro Technologies Inc. (TSX: EXRO) (“Exro” or the “Company”) provides the following corporate... Read more.
Find Your Grind Earns ESSA Tier 2 Validation, Expands Future-Ready Learning Nationwide
Career-Planning Platform Celebrates Three Major Milestones This Back-to-School Season LOS ANGELES, Sept. 3, 2025 /PRNewswire/ — As the top learning solution... Read more.
DIRECTV Financing, LLC and DIRECTV Financing Co-Obligor, Inc. Announce Tender Offer for Up to $1,500,000,000 in Aggregate Principal Amount of Their 5.875% Senior Notes Due 2027
EL SEGUNDO, Calif., Sept. 3, 2025 /PRNewswire/ — DIRECTV Financing, LLC, a Delaware limited liability company (“DIRECTV Financing”) and DIRECTV... Read more.
Aurzen Redefines Portable Entertainment with New Projector Lineup for Every Lifestyle at IFA 2025
Highlights include the hyper-versatile ZIP modular projection platform and the audio-centric BOOM series; live demos at Hall H21, Booth H21-111. BERLIN, Sept. 3,... Read more.
SpliSense Reports Positive Results from Phase 2 Study of SPL84 in Cystic Fibrosis
Results mark first evidence of potential clinical benefit of antisense oligonucleotide therapy in a pulmonary disease Encouraging safety profile with no identified... Read more.
CUJO AI Appoints Former Charter Executive Kyle Johnson as Chief Customer Officer
LOS ANGELES, Sept. 3, 2025 /PRNewswire/ — CUJO AI, the global leader in AI-powered cybersecurity and device intelligence solutions for network service providers... Read more.
Galvanize Therapeutics raises $100 million in Oversubscribed Series C Financing to Transform the Treatment of Cancer and Chronic Lung Disease
Sofinnova Partners leads premier investor syndicate backing Galvanize’s breakthrough pulsed electric field (PEF) platform—a first-of-its-kind, non-drug approach... Read more.
Shift5 Raises $75 Million Series C to Scale Operational Intelligence Platform for Critical Defense and Commercial Transportation Assets
Investment to accelerate deployment of technology that gives maintenance, operations, and cybersecurity teams visibility into fleet performance and security ARLINGTON,... Read more.